Profund Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Sell |
20,950
-3,653
| -15% | -$23.7K | ﹤0.01% | 948 |
|
|
2025
Q1 | $195K | Sell |
24,603
-5,821
| -19% | -$46.2K | 0.01% | 912 |
|
|
2024
Q4 | $385K | Buy |
30,424
+3,533
| +13% | +$44.8K | 0.01% | 645 |
|
|
2024
Q3 | $375K | Sell |
26,891
-716
| -3% | -$9.97K | 0.01% | 676 |
|
|
2024
Q2 | $380K | Sell |
27,607
-3,005
| -10% | -$41.4K | 0.01% | 590 |
|
|
2024
Q1 | $506K | Sell |
30,612
-8,205
| -21% | -$136K | 0.02% | 573 |
|
|
2023
Q4 | $567K | Sell |
38,817
-1,428
| -4% | -$20.8K | 0.02% | 477 |
|
|
2023
Q3 | $494K | Sell |
40,245
-12,387
| -24% | -$152K | 0.03% | 472 |
|
|
2023
Q2 | $628K | Buy |
52,632
+17,303
| +49% | +$207K | 0.03% | 433 |
|
|
2023
Q1 | $472K | Buy |
+35,329
| New | +$472K | 0.03% | 518 |
|